221 related articles for article (PubMed ID: 25731616)
21. Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, meta-analysis and cross-species comparison.
Lu X; Sun W; Tang Y; Zhu L; Li Y; Ou C; Yang C; Su J; Luo C; Hu Y; Cao J
Mol Med Rep; 2016 Feb; 13(2):1172-8. PubMed ID: 26647881
[TBL] [Abstract][Full Text] [Related]
22. A transcriptome profile in hepatocellular carcinomas based on integrated analysis of microarray studies.
Wang F; Wang R; Li Q; Qu X; Hao Y; Yang J; Zhao H; Wang Q; Li G; Zhang F; Zhang H; Zhou X; Peng X; Bian Y; Xiao W
Diagn Pathol; 2017 Jan; 12(1):4. PubMed ID: 28086821
[TBL] [Abstract][Full Text] [Related]
23. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
24. Increased Copy Number of the Gene Encoding SF3B4 Indicates Poor Prognosis in Hepatocellular Carcinoma.
Iguchi T; Komatsu H; Masuda T; Nambara S; Kidogami S; Ogawa Y; Hu Q; Saito T; Hirata H; Sakimura S; Uchi R; Hayashi N; Ito S; Eguchi H; Sugimachi K; Maehara Y; Mimori K
Anticancer Res; 2016 May; 36(5):2139-44. PubMed ID: 27127115
[TBL] [Abstract][Full Text] [Related]
25. Gene expression signature of human HepG2 cell line.
Costantini S; Di Bernardo G; Cammarota M; Castello G; Colonna G
Gene; 2013 Apr; 518(2):335-45. PubMed ID: 23357223
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L
Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542
[TBL] [Abstract][Full Text] [Related]
27. Bioinformatics-based screening of key genes for transformation of liver cirrhosis to hepatocellular carcinoma.
Jiang CH; Yuan X; Li JF; Xie YF; Zhang AZ; Wang XL; Yang L; Liu CX; Liang WH; Pang LJ; Zou H; Cui XB; Shen XH; Qi Y; Jiang JF; Gu WY; Li F; Hu JM
J Transl Med; 2020 Jan; 18(1):40. PubMed ID: 32000807
[TBL] [Abstract][Full Text] [Related]
28. Insights into significant pathways and gene interaction networks in peripheral blood mononuclear cells for early diagnosis of hepatocellular carcinoma.
Jiang JX; Yu C; Li ZP; Xiao J; Zhang H; Chen MY; Sun CY
J Cancer Res Ther; 2016; 12(2):981-9. PubMed ID: 27461685
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of tumor-associated trypsin inhibitor (SPINK1/TATI) in hepatitis C-associated hepatocellular carcinoma: potential implications for viral hepatocarcinogenesis.
Hass HG; Jobst J; Vogel U; Scheurlen M; Nehls O
Oncol Res Treat; 2014; 37(12):732-8. PubMed ID: 25531719
[TBL] [Abstract][Full Text] [Related]
30. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNAs and genes contributing to the generation of cancer stem cells in hepatocellular carcinoma identified by RNA sequencing analysis.
Cao L; Zhang Q; Cheng S; Chen Z; Hua Z; Yang J; Liu D; Cui N
Oncol Rep; 2016 Nov; 36(5):2619-2624. PubMed ID: 27667473
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of genes during aflatoxin B(1)-induced hepatocarcinogenesis in tree shrews.
Li Y; Wan DF; Su JJ; Cao J; Ou C; Qiu XK; Ban KC; Yang C; Qin LL; Luo D; Yue HF; Zhang LS; Gu JR
World J Gastroenterol; 2004 Feb; 10(4):497-504. PubMed ID: 14966905
[TBL] [Abstract][Full Text] [Related]
33. Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray.
Liu Y; Zhu X; Zhu J; Liao S; Tang Q; Liu K; Guan X; Zhang J; Feng Z
Oncol Rep; 2007 Oct; 18(4):943-51. PubMed ID: 17786358
[TBL] [Abstract][Full Text] [Related]
34. Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique.
He TL; Zheng KL; Li G; Song B; Zhang YJ
Eur Rev Med Pharmacol Sci; 2014; 18(1):108-16. PubMed ID: 24452951
[TBL] [Abstract][Full Text] [Related]
35. Identification of personalized dysregulated pathways in hepatocellular carcinoma.
Li H; Jiang X; Zhu S; Sui L
Pathol Res Pract; 2017 Apr; 213(4):327-332. PubMed ID: 28215647
[TBL] [Abstract][Full Text] [Related]
36. Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma.
Soto M; Reviejo M; Al-Abdulla R; Romero MR; Macias RIR; Boix L; Bruix J; Serrano MA; Marin JJG
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165687. PubMed ID: 31953214
[TBL] [Abstract][Full Text] [Related]
37. Mongolian HCC vs. Caucasian HCC: The Metabolic Reprogramming Process in Mongolian HCC is an Interesting Difference.
Huang R; Yang K; Zhang Z; Song L; Dong K; Xie X; Hai X
Biochem Genet; 2024 Jun; 62(3):2279-2295. PubMed ID: 37907705
[TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells.
Ding M; Li J; Yu Y; Liu H; Yan Z; Wang J; Qian Q
J Transl Med; 2015 Aug; 13():259. PubMed ID: 26259570
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.
Agarwal R; Narayan J; Bhattacharyya A; Saraswat M; Tomar AK
Cancer Genet; 2017 Oct; 216-217():37-51. PubMed ID: 29025594
[TBL] [Abstract][Full Text] [Related]
40. Aberrant gene expression profiles in hepatocellular carcinoma detected by microdissection.
Wei YM; Li YY; Zhang YC; Nie YQ
Genet Mol Res; 2013 Nov; 12(4):5527-36. PubMed ID: 24301923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
